Article (Scientific journals)
Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice.
Hanson, Julien; Gille, Andreas; Zwykiel, Sabrina et al.
2010In Journal of Clinical Investigation, 120 (8), p. 2910-9
Peer Reviewed verified by ORBi
 

Files


Full Text
JCI42273.v2(2).pdf
Publisher postprint (4.29 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Animals; Cells, Cultured; Cyclooxygenase 1/physiology; Cyclooxygenase 2/physiology; Dinoprostone/biosynthesis; Flushing/chemically induced; Fumarates/toxicity; Humans; Keratinocytes/metabolism; Langerhans Cells/metabolism; Mice; Mice, Inbred C57BL; Niacin/toxicity; Receptors, G-Protein-Coupled/genetics/physiology; Receptors, Nicotinic/genetics/physiology
Abstract :
[en] The antidyslipidemic drug nicotinic acid and the antipsoriatic drug monomethyl fumarate induce cutaneous flushing through activation of G protein-coupled receptor 109A (GPR109A). Flushing is a troublesome side effect of nicotinic acid, but may be a direct reflection of the wanted effects of monomethyl fumarate. Here we analyzed the mechanisms underlying GPR109A-mediated flushing and show that both Langerhans cells and keratinocytes express GPR109A in mice. Using cell ablation approaches and transgenic cell type-specific GPR109A expression in Gpr109a-/- mice, we have provided evidence that the early phase of flushing depends on GPR109A expressed on Langerhans cells, whereas the late phase is mediated by GPR109A expressed on keratinocytes. Interestingly, the first phase of flushing was blocked by a selective cyclooxygenase-1 (COX-1) inhibitor, and the late phase was sensitive to a selective COX-2 inhibitor. Both monomethyl fumarate and nicotinic acid induced PGE2 formation in isolated keratinocytes through activation of GPR109A and COX-2. Thus, the early and late phases of the GPR109A-mediated cutaneous flushing reaction involve different epidermal cell types and prostanoid-forming enzymes. These data will help to guide new efficient approaches to mitigate nicotinic acid-induced flushing and may help to exploit the potential antipsoriatic effects of GPR109A agonists in the skin.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Hanson, Julien  ;  Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Gille, Andreas
Zwykiel, Sabrina
Lukasova, Martina
Clausen, Bjorn E
Ahmed, Kashan
Tunaru, Sorin
Wirth, Angela
Offermanns, Stefan
Language :
English
Title :
Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice.
Publication date :
2010
Journal title :
Journal of Clinical Investigation
ISSN :
0021-9738
eISSN :
1558-8238
Publisher :
American Society for Clinical Investigation, Ann Arbor, United States - Michigan
Volume :
120
Issue :
8
Pages :
2910-9
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 24 November 2010

Statistics


Number of views
126 (18 by ULiège)
Number of downloads
1 (1 by ULiège)

Scopus citations®
 
155
Scopus citations®
without self-citations
136
OpenCitations
 
132

Bibliography


Similar publications



Contact ORBi